Inflammation mediated by chemokine and cytokine signaling pathway |
2.70E-08 |
0.0000048 |
Toll receptor signaling pathway |
7.66E-05 |
0.0135 |
T cell activation |
4.75E-03 |
0.835 |
p38 MAPK pathway |
5.38E-03 |
0.946 |
JAK/STAT signaling pathway |
7.59E-03 |
1 |
Beta3 adrenergic receptor signaling pathway |
0.02 |
1 |
Integrin signalling pathway |
0.02 |
1 |
B cell activation |
0.02 |
1 |
Interferon-gamma signaling pathway |
0.02 |
1 |
Opioid prodynorphin pathway |
0.02 |
1 |
Opioid proenkephalin pathway |
0.02 |
1 |
5HT4 type receptor mediated signaling pathway |
0.02 |
1 |
Opioid proopiomelanocortin pathway |
0.03 |
1 |
Salvage pyrimidine deoxyribonucleotides |
0.03 |
1 |
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway |
0.04 |
1 |
Nicotinic acetylcholine receptor signaling pathway |
0.04 |
1 |
Parkinson disease |
0.04 |
1 |
Beta2 adrenergic receptor signaling pathway |
0.04 |
1 |
Beta1 adrenergic receptor signaling pathway |
0.04 |
1 |
5HT1 type receptor mediated signaling pathway |
0.04 |
1 |